Superberg said that millions of people can die worldwide and pay global economic costs of less than 2TN every year until 2050, modeling said.
A study by the British government shows that if there is no joint behavior, the increase in antimicrobial resistance (AMR) can lead to the world. Annual GDP loss $ 1.7TN During the next century.
research, Global Development Center Thinktank, the United States, the United Kingdom, and the EU economy have been found to be the biggest blow.
Thursday, the British government announced this Ax Fund for Fleming FundAs part of a wider aid cut, fighting AMR in low and intermediate income countries. The Trump administration confirmed the cut of $ 9 billion in foreign aid budgets, and many European countries have reduced spending on overseas aid.
Anthony McDonnel, the policy author of the Global Development Center for Global Development Center, said: “When we conducted research on the economic impact of antibacterial resistance It was expected to be followed.
“But sudden cuts on US development support have reduced the US aid to a 80% decrease by about 80%, and the United Kingdom will increase the resistance rate according to the most familiar frequency in our study by publishing aid reduction and a significant decline in France, Germany and others, from 0.5% to 0.3% of the total national income.
“Even countries that have succeeded in controlling the AMR rate are not satisfied. The AMR program will increase the rate of resistance around the world unless it is protected from aid cuts.
“This will lead to millions of people around the world, including the G7 countries. Investment in bacterial infections will now save life and deliver billions of billions of economic profits.”
The study predicts that the economic and health burden of antibiotic resistance in 122 countries can be reached by 2050, and by 2050, China’s GDP losses can reach $ 72.2 billion annually, EU $ 18.7 billion, Japan $ 65.7bn and the UK $ 58.6bn.
According to Health indicator and evaluation research institute (IHME) The death of AMR is expected to increase by 60% by 2050, and only 1.34 million in the United States and 184,000 in the United Kingdom will die as antibiotic resistant bugs, while the number of people seriously sick in drug -resistant bacteria is expected to jump.
Superberg increases the number of hospital inpatients, leading to longer, more intensive hospital stays, cost -cost secondary and more complicated treatment. In other words, resistance infection is about twice as much antibiotic than effective.
The study estimates that the global health costs for AMR treatment are only $ 17.6 billion annually, while in the UK, it will increase from $ 900 million to $ 3.7 billion and $ 15.5 billion to $ 57 billion in the United States.
The high proportion of resistance bugs will also reduce the UK, EU and US personnel to 0.8%, 0.6% and 0.4%, respectively, according to a study.
But more investment in the country dealing with superbugs-increasing access to new antibiotics and high-quality treatment for these infections-US economy will increase $ 156.2 billion annually, and the United Kingdom will increase $ 12 billion (£ 9.3 billion) by 2050.
According to the findings, Dr. Mohsen Naghavi, a professor of health indicators of IHME, said: “Today’s threats are increasing today, and drugs we can use without the immediate action of all stakeholders can stop working.
He added that policy changes in the United States, Europe and the British government, new drug development and all people will guarantee that antibiotics are not effective in viruses.
A British government spokesman said: “Our 10 -year health plan recognizes antimicrobial resistance (AMR) as its main threat and strives to solve spreads, including new vaccines.
“We have achieved important progress in reducing the use of antibiotics in meat and pioneering the world’s first subscription model to encourage the development of new treatment. We are also working closely with international partners to affect global efforts to limit the spread of AMR.”
